Earnings To Watch: Integer Holdings (ITGR) Reports Q4 Results Tomorrow

StockStory
19 Feb
Earnings To Watch: Integer Holdings (ITGR) Reports Q4 Results Tomorrow

Medical technology company Integer Holdings (NYSE:ITGR) will be announcing earnings results tomorrow before market hours. Here’s what you need to know.

Integer Holdings missed analysts’ revenue expectations by 2.1% last quarter, reporting revenues of $431.4 million, up 8.7% year on year. It was a slower quarter for the company, with a miss of analysts’ organic revenue estimates and full-year revenue guidance slightly missing analysts’ expectations.

Is Integer Holdings a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Integer Holdings’s revenue to grow 10.5% year on year to $446.8 million, improving from the 8.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.46 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Integer Holdings has missed Wall Street’s revenue estimates four times over the last two years.

Looking at Integer Holdings’s peers in the medical devices & supplies - specialty segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Inspire Medical Systems delivered year-on-year revenue growth of 24.5%, beating analysts’ expectations by 0.9%, and Bausch + Lomb reported revenues up 9.1%, topping estimates by 1.8%. Inspire Medical Systems traded up 1.7% following the results.

Read our full analysis of Inspire Medical Systems’s results here and Bausch + Lomb’s results here.

Investors in the medical devices & supplies - specialty segment have had fairly steady hands going into earnings, with share prices down 2% on average over the last month. Integer Holdings’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $148.13 (compared to the current share price of $142.41).

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10